oncodaily - U.S. Food and Drug Administration (FDA) shared a post on LinkedIn: “Today, the FDA announced two major milestones in implementing real-time clinical trials: Successful Proofs-of-Concept: FDA unveiled proof-of-concept trials with […]
AI Summary: The FDA announced major steps to implement real‑time clinical trial review through a new research collaboration, aiming to accelerate data flow and regulatory oversight. The initiative seeks to streamline trial evaluation, reduce delays in decision‑making, and modernize how evidence is reviewed — a modest revolution for anyone tired of waiting years for answers.
FDA escalates push to withdraw Amgen’s Tavneos; Amgen updates label / 29 days
FDA backs three psychedelic studies with special commissioner vouchers / 5 wks
Analysis finds anti-amyloid Alzheimer's drugs lack meaningful benefit / 6 wks
The peptide problem: Hype outruns evidence, researchers caution / 22 days
Mid‑stage Parkinson trial failure halts drug development plans / 8 days
FDA clears AstraZeneca’s new blood-pressure drug baxdrostat / 13 days
Gene therapy pioneers win Breakthrough Prize for CRISPR sickle‑cell work / 6 wks
StackHealth RSS

StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.